[Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer].
Investigations of estrogen and progesterone receptors content in 28 women with endometrial cancer in the cancer tissue. During treatment with large doses of MPA (Depo-Provera) a significant decrease of progesterone receptors was observed.